324 related articles for article (PubMed ID: 23598854)
1. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
Jedrych J; McNiff JM
Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
[TBL] [Abstract][Full Text] [Related]
2. Microcystic adnexal carcinoma: an immunohistochemical reappraisal.
Hoang MP; Dresser KA; Kapur P; High WA; Mahalingam M
Mod Pathol; 2008 Feb; 21(2):178-85. PubMed ID: 18065959
[TBL] [Abstract][Full Text] [Related]
3. p75 Neurotrophin receptor differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma: insights into the histogenesis of adnexal tumours based on embryology and hair follicle biology.
Krahl D; Sellheyer K
Br J Dermatol; 2010 Jul; 163(1):138-45. PubMed ID: 20184585
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
Krahl D; Sellheyer K
J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
[TBL] [Abstract][Full Text] [Related]
5. Desmoplastic trichoepithelioma, infiltrative/morpheaform BCC, and microcystic adnexal carcinoma: differentiation by immunohistochemistry and determining the need for Mohs micrographic surgery.
Merritt BG; Snow SN; Longley BJ
Cutis; 2010 May; 85(5):254-8. PubMed ID: 20540416
[TBL] [Abstract][Full Text] [Related]
6. Microcystic adnexal carcinoma versus desmoplastic trichoepithelioma: a comparative study.
Tse JY; Nguyen AT; Le LP; Hoang MP
Am J Dermatopathol; 2013 Feb; 35(1):50-5. PubMed ID: 22722464
[TBL] [Abstract][Full Text] [Related]
7. PHLDA1, a follicular stem cell marker, differentiates clear-cell/granular-cell trichoblastoma and clear-cell/granular cell basal cell carcinoma: a case-control study, with first description of granular-cell trichoblastoma.
Battistella M; Peltre B; Cribier B
Am J Dermatopathol; 2014 Aug; 36(8):643-50. PubMed ID: 23719479
[TBL] [Abstract][Full Text] [Related]
8. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens.
Sellheyer K; Nelson P
J Cutan Pathol; 2011 Jul; 38(7):542-50. PubMed ID: 21352265
[TBL] [Abstract][Full Text] [Related]
9. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
Sellheyer K; Nelson P; Kutzner H; Patel RM
J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma.
Abbas O; Richards JE; Mahalingam M
Mod Pathol; 2010 Nov; 23(11):1535-43. PubMed ID: 20711172
[TBL] [Abstract][Full Text] [Related]
11. P75 neurotrophin receptor expression in squamous cell carcinoma.
Anolik RB; Aung PP; Bhawan J
Am J Dermatopathol; 2015 Feb; 37(2):160-1. PubMed ID: 25321086
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
Evangelista MT; North JP
J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
[TBL] [Abstract][Full Text] [Related]
13. Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?
Katona TM; Perkins SM; Billings SD
J Cutan Pathol; 2008 Feb; 35(2):174-9. PubMed ID: 18190441
[TBL] [Abstract][Full Text] [Related]
14. Does Immunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepithelioma, Morpheaform Basal Cell Carcinoma, and Microcystic Adnexal Carcinoma?
Mohanty SK; Sardana R; McFall M; Pradhan D; Usmani A; Jha S; Mishra SK; Sampat NY; Lobo A; Wu JM; Balzer BL; Frishberg DP
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):273-277. PubMed ID: 35384877
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous neuroendocrine cell carcinoma (Merkel cell carcinoma) with prominent microcystic features, mimicking eccrine carcinoma.
Li N; Wolgamot G; Argenyi Z
J Cutan Pathol; 2007 May; 34(5):410-4. PubMed ID: 17448197
[TBL] [Abstract][Full Text] [Related]
16. Desmoplastic trichoepithelioma with perineural involvement: a series of seven cases.
Jedrych J; Leffell D; McNiff JM
J Cutan Pathol; 2012 Mar; 39(3):317-23. PubMed ID: 22335590
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of PHLDA1 (TDAG51) in basal cell carcinoma and trichoepithelioma.
Yeh I; McCalmont TH; LeBoit PE
Br J Dermatol; 2012 Nov; 167(5):1106-10. PubMed ID: 22958125
[TBL] [Abstract][Full Text] [Related]
18. CXCR-4 and COX-2 expression in basal cell carcinomas and well-differentiated squamous cell carcinomas of the skin; their relationship with tumor invasiveness and histological subtype.
Sivrikoz ON; Uyar B; Dağ F; Taşlı F; Sanal SM
Turk Patoloji Derg; 2015; 31(1):30-5. PubMed ID: 25301050
[TBL] [Abstract][Full Text] [Related]
19. [Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma].
Mitcov M; Scrivener Y; Cribier B
Ann Dermatol Venereol; 2009; 136(6-7):501-7. PubMed ID: 19560610
[TBL] [Abstract][Full Text] [Related]
20. Ln-γ 2 chain of laminin-332 is a useful marker in differentiating between benign and malignant sclerosing adnexal neoplasms.
Koga K; Anan T; Fukumoto T; Fujimoto M; Nabeshima K
Histopathology; 2020 Jan; 76(2):318-324. PubMed ID: 31429981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]